Next Article in Journal
Review of Histopathological and Molecular Prognostic Features in Colorectal Cancer
Next Article in Special Issue
Tumor Necrosis Factor (TNF) and Chemokines in Colitis-Associated Cancer
Previous Article in Journal
TRAF4, at the Crossroad between Morphogenesis and Cancer
Cancers 2011, 3(2), 2750-2766; doi:10.3390/cancers3022750
Article

Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis

, *  and
Received: 13 May 2011; in revised form: 9 June 2011 / Accepted: 14 June 2011 / Published: 22 June 2011
(This article belongs to the Special Issue Exploring Inflammation in Cancers)
View Full-Text   |   Download PDF [297 KB, uploaded 22 June 2011]   |   Browse Figures
Abstract: Genetic abnormalities such as nucleotide alterations and chromosomal disorders that accumulate in various tumor-related genes have an important role in cancer development. The precise mechanism of the acquisition of genetic aberrations, however, remains unclear. Activation-induced cytidine deaminase (AID), a nucleotide editing enzyme, is essential for the diversification of antibody production. AID is expressed only in activated B lymphocytes under physiologic conditions and induces somatic hypermutation and class switch recombination in immunoglobulin genes. Inflammation leads to aberrant AID expression in various gastrointestinal organs and increased AID expression contributes to cancer development by inducing genetic alterations in epithelial cells. Studies of how AID induces genetic disorders are expected to elucidate the mechanism of inflammation-associated carcinogenesis.
Keywords: activation-induced cytidine deaminase; inflammation; carcinogenesis; genetic alteration activation-induced cytidine deaminase; inflammation; carcinogenesis; genetic alteration
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Takai, A.; Marusawa, H.; Chiba, T. Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis. Cancers 2011, 3, 2750-2766.

AMA Style

Takai A, Marusawa H, Chiba T. Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis. Cancers. 2011; 3(2):2750-2766.

Chicago/Turabian Style

Takai, Atsushi; Marusawa, Hiroyuki; Chiba, Tsutomu. 2011. "Acquisition of Genetic Aberrations by Activation-Induced Cytidine Deaminase (AID) during Inflammation-Associated Carcinogenesis." Cancers 3, no. 2: 2750-2766.


Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert